Next Article in Journal
p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX
Next Article in Special Issue
Class II PI3Ks at the Intersection between Signal Transduction and Membrane Trafficking
Previous Article in Journal
Extreme Fuzziness: Direct Interactions between Two IDPs
Previous Article in Special Issue
Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K
Review

Structural Determinants of Isoform Selectivity in PI3K Inhibitors

1
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
2
Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Parkville, VIC 3052, Australia
3
Departments of Medicine, Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
*
Author to whom correspondence should be addressed.
Biomolecules 2019, 9(3), 82; https://doi.org/10.3390/biom9030082
Received: 25 January 2019 / Accepted: 21 February 2019 / Published: 26 February 2019
(This article belongs to the Special Issue Phosphoinositide 3-kinase, a Field in Transition)
Phosphatidylinositol 3-kinases (PI3Ks) are important therapeutic targets for the treatment of cancer, thrombosis, and inflammatory and immune diseases. The four highly homologous Class I isoforms, PI3Kα, PI3Kβ, PI3Kγ and PI3Kδ have unique, non-redundant physiological roles and as such, isoform selectivity has been a key consideration driving inhibitor design and development. In this review, we discuss the structural biology of PI3Ks and how our growing knowledge of structure has influenced the medicinal chemistry of PI3K inhibitors. We present an analysis of the available structure-selectivity-activity relationship data to highlight key insights into how the various regions of the PI3K binding site influence isoform selectivity. The picture that emerges is one that is far from simple and emphasizes the complex nature of protein-inhibitor binding, involving protein flexibility, energetics, water networks and interactions with non-conserved residues. View Full-Text
Keywords: PIK3CA; isoform selectivity; p110; p85; phosphatidylinositol 3-kinase; PI3Kβ; PI3Kα; PI3Kγ; PI3Kδ PIK3CA; isoform selectivity; p110; p85; phosphatidylinositol 3-kinase; PI3Kβ; PI3Kα; PI3Kγ; PI3Kδ
Show Figures

Graphical abstract

MDPI and ACS Style

Miller, M.S.; Thompson, P.E.; Gabelli, S.B. Structural Determinants of Isoform Selectivity in PI3K Inhibitors. Biomolecules 2019, 9, 82. https://doi.org/10.3390/biom9030082

AMA Style

Miller MS, Thompson PE, Gabelli SB. Structural Determinants of Isoform Selectivity in PI3K Inhibitors. Biomolecules. 2019; 9(3):82. https://doi.org/10.3390/biom9030082

Chicago/Turabian Style

Miller, Michelle S.; Thompson, Philip E.; Gabelli, Sandra B. 2019. "Structural Determinants of Isoform Selectivity in PI3K Inhibitors" Biomolecules 9, no. 3: 82. https://doi.org/10.3390/biom9030082

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop